First FDA-Cleared Respirators for Use in Public Health Medical Emergencies Now Available from 3M (MMM)
More News related to MMM
- 3M Completes Acquisition of Meguiar's Inc.
- The Stanley Works Elects Patrick D. Campbell to Board of Directors
- Scotch Power Cable Jacket Repair Tape Stands up to Abuse
- 3M to Webcast Third-Quarter Earnings Conference Call
- Entrust, 3M Collaborate to Provide End-to-End Secure ePassport Solution
Consumers concerned about an influenza outbreak can breathe a little easier: 3M (NYSE: MMM) has just released two new NIOSH N95 respirators for use by the general public in public health medical emergencies.
These two respirators--3M(TM) Particulate Respirator 8612F and 3M(TM) Particulate Respirator 8670F--are unique because they are the first to receive clearance by the FDA to reduce exposure to airborne germs during a public health medical emergency such as an influenza pandemic. The FDA outlined a special clearance process for N95 respirators used by the general public in public health medical emergencies in order to provide reasonable assurance of their safety and effectiveness.
Related Categories
FDAStocks Mentioned
-2.27Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
